Alexander Roussanov discusses his time as the former senior legal adviser at the European Medicines Agency (EMA). What is the best way to interact with the agency and how can companies find win-win solutions without unneeded conflict?
Hear more from Alexander and our entire UK/EU Life Sciences team at this year's UK & EU Annual Life Sciences Conference.
This is the latest in our series: "Insights: Life Sciences" where we examine the legal issues and trends impacting the life sciences and healthcare industries.
ยป See the rest of the "Insights: Life Sciences" series here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
